<DOC>
	<DOCNO>NCT02644707</DOCNO>
	<brief_summary>To investigate whether supplementation organic selenium `` adult '' dose ( 200 mcg per day form L-selenomethionine ) favorable impact thyroid function , include titer anti-thyroid antibody [ Anti-thyroid peroxidase ( anti-TPO ) Anti-thyroglobulin ( anti-Tg ) antibody ] , child adolescent autoimmune thyroiditis ( AT ) .</brief_summary>
	<brief_title>Selenium Supplementation Youths With Autoimmune Thyroiditis</brief_title>
	<detailed_description>Background : Selenium form seleno-cysteine essential component enzyme remove toxic substance body , glutathione peroxidase ( GPX ) thyroid cell well seleno-dependent iodothyronine deiodinase catalyse extra-thyroidal production triiodothyronine ( T3 ) . In general , selenium deficiency may influence production free radical , conversion thyroxine T4 T3 , cytokine production immune mechanism . Thus , previously suggest supplementation may beneficial effect patient autoimmune thyroiditis , especially increased inflammatory activity high antibody titer . Although two study far conduct pediatric population demonstrate significant effect selenium administration titre antibody , researcher administer selenium either form inorganic sodium selenite `` adult '' dose ( 100-200 mcg daily ) form organic L-selenomethionine reduce dose ( 50 mcg daily ) . Therefore , best knowledge , selenium supplementation form organic L-selenomethionine `` adult '' dose ( 200 mcg daily ) investigate child adolescent autoimmune thyroiditis ( AT ) far . Objective : Our aim investigate whether supplementation organic selenium `` adult '' dose ( 200 mcg per day form L-selenomethionine ) favorable impact thyroid function , include titer anti-thyroid antibody ( thyroid-peroxidase antiTPO , thyroglobulin -antiTg- antibody ) , child adolescent autoimmune thyroiditis ( AT ) . Design Methods : This randomize blind placebo-controlled clinical trial selenium supplementation versus placebo child adolescent autoimmune thyroiditis ( AT ) . The trial include 100 consecutive participant ( 50 participant arm ) Unit Pediatric Endocrinology 4th Department Pediatrics , Medical School , Aristotle University Thessaloniki , Greece . The patient inform give write consent include study . The subject randomize receive either organic selenium form L-selenomethionine dose 200mcg daily ( intervention group ) placebo ( control group ) 6 month . Both group receive oral tablet ( one daily ) , identical appearance , taste smell differ type active substance ( L-selenomethionine placebo ) . Six month additional follow-up lead trial duration 12 month . The experimental supplement give Pharmaceutical company marketing product SEMED200Â® ( INTERMED Pharmaceutical Laboratories ) . In participant , determination concentration thyroid-stimulating hormone ( TSH ) , free thyroxine ( fT4 ) , thyroid peroxidase antibody ( TPOAb ) , thyroglobulin antibody ( TgAb ) make four time ( 0 , 3 , 6 12 month ) . Thyroid volume morphology also sonographically evaluate three time ( 0 , 6 12 month ) . Serum selenium level form selenomethionine also determine ( begin study ) . Time-schedule : January- February 2015 : protocol preparation . March 2015 : first participant 's first visit . March 2016 : last participant 's first visit . September 2016 : last participant 's last visit . September - October 2016 : analysis biological sample data , preparation manuscript , March 2017 : last participant 's completion follow-up .</detailed_description>
	<mesh_term>Thyroiditis</mesh_term>
	<mesh_term>Thyroiditis , Autoimmune</mesh_term>
	<mesh_term>Hashimoto Disease</mesh_term>
	<mesh_term>Selenium</mesh_term>
	<criteria>A positive titer antithyroid peroxidase ( antiTPO ) antithyroglobulin ( antiTg ) antibody ( TPO / Tg &gt; 60 IU / ml ) least one : Abnormal thyroid function require substitution treatment Lthyroxine ( TSH &gt; 5 microunits per milliliter ( mcU/ml ) decrease normal level fT4 fT3 ) Increased volume thyroid gland ( goiter ) Morphological change ultrasound thyroid gland Presence another chronic disease autoimmune disease medication Age diagnosis 18 year</criteria>
	<gender>All</gender>
	<minimum_age>4 Years</minimum_age>
	<maximum_age>18 Years</maximum_age>
	<verification_date>December 2015</verification_date>
</DOC>